114 related articles for article (PubMed ID: 3002815)
1. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.
Corsini GU; Pintus S; Chiueh CC; Weiss JF; Kopin IJ
Eur J Pharmacol; 1985 Dec; 119(1-2):127-8. PubMed ID: 3002815
[No Abstract] [Full Text] [Related]
2. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources.
Heikkila RE
Eur J Pharmacol; 1985 Oct; 117(1):131-3. PubMed ID: 3878793
[TBL] [Abstract][Full Text] [Related]
3. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde.
Corsini GU; Zuddas A; Bonuccelli U; Schinelli S; Kopin IJ
Life Sci; 1987 Mar; 40(9):827-32. PubMed ID: 2434820
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Youngster SK; Sonsalla PK; Heikkila RE
J Neurochem; 1987 Mar; 48(3):929-34. PubMed ID: 3492590
[TBL] [Abstract][Full Text] [Related]
5. A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity.
Fuller RW; Hemrick-Luecke SK
J Pharm Pharmacol; 1989 Jul; 41(7):492-3. PubMed ID: 2570859
[TBL] [Abstract][Full Text] [Related]
6. Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson's disease induced by co-administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.
Shimazu S; Takahata K; Tamashiro A; Yoneda F; Iida Y; Saji H
J Neural Transm (Vienna); 2003 Aug; 110(8):871-83. PubMed ID: 12898343
[TBL] [Abstract][Full Text] [Related]
7. Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice.
Gerlach M; Russ H; Winker J; Witzmann K; Traber J; Stasch JP; Riederer P; Przuntek H
Arzneimittelforschung; 1993 Apr; 43(4):413-5. PubMed ID: 7684224
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Heikkila RE; Nicklas WJ; Duvoisin RC
Adv Neurol; 1987; 45():149-52. PubMed ID: 3103384
[No Abstract] [Full Text] [Related]
9. Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors.
Fuller RW; Hemrick-Luecke SK; Robertson DW
Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):57-65. PubMed ID: 2417293
[TBL] [Abstract][Full Text] [Related]
10. Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?
Russ H; Mihatsch W; Gerlach M; Riederer P; Przuntek H
Neurosci Lett; 1991 Feb; 123(1):115-8. PubMed ID: 1712088
[TBL] [Abstract][Full Text] [Related]
11. Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease.
Collins MA; Neafsey EJ; Cheng BY; Hurley-Gius K; Ung-Chhun NA; Pronger DA; Christensen MA; Hurley-Gius D
Adv Neurol; 1987; 45():179-82. PubMed ID: 3493625
[No Abstract] [Full Text] [Related]
12. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke.
Carr LA; Rowell PP
Neuropharmacology; 1990 Mar; 29(3):311-4. PubMed ID: 2325834
[TBL] [Abstract][Full Text] [Related]
13. The effect of diethyldithiocarbamate on the biodisposition of MPTP: an explanation for enhanced neurotoxicity.
Irwin I; Wu EY; DeLanney LE; Trevor A; Langston JW
Eur J Pharmacol; 1987 Sep; 141(2):209-17. PubMed ID: 2824216
[TBL] [Abstract][Full Text] [Related]
14. Tissue culture model for studying MPTP toxicity to dopamine neurons.
Mytilineou C; Cohen G
Adv Neurol; 1987; 45():145-8. PubMed ID: 3493622
[No Abstract] [Full Text] [Related]
15. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
Mayer RA; Walters AS; Heikkila RE
Eur J Pharmacol; 1986 Jan; 120(3):375-7. PubMed ID: 2868908
[TBL] [Abstract][Full Text] [Related]
16. Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice.
Renoux G; Bizière K; Renoux M; Steinberg R; Kan JP; Guillaumin JM
Life Sci; 1989; 44(12):771-7. PubMed ID: 2539542
[TBL] [Abstract][Full Text] [Related]
17. Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Chiba K; Kubota E; Miyakawa T; Kato Y; Ishizaki T
J Pharmacol Exp Ther; 1988 Sep; 246(3):1108-15. PubMed ID: 3262153
[TBL] [Abstract][Full Text] [Related]
18. Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Schumm S; Sebban C; Cohen-Salmon C; Callebert J; Launay JM; Golmard JL; Boussicault L; Petropoulos I; Hild A; Rousselet E; Prigent A; Friguet B; Mariani J; Hirsch EC
J Neurochem; 2012 Sep; 122(5):1032-46. PubMed ID: 22708926
[TBL] [Abstract][Full Text] [Related]
19. Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Yurek DM; Deutch AY; Roth RH; Sladek JR
Brain Res; 1989 Sep; 497(2):250-9. PubMed ID: 2573405
[TBL] [Abstract][Full Text] [Related]
20. Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones.
Boyce S; Kelly E; Reavill C; Jenner P; Marsden CD
Biochem Pharmacol; 1984 Jun; 33(11):1747-52. PubMed ID: 6610420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
